This is especially important considering the increasing use of these medications. The authors write that, to their knowledge, this is the first case detailing a patient developing this serious condition after starting tirzepatide for diabetes (in contrast to those treated with tirzepatide for weight loss)
And that boxed warning, the most serious label the FDA can apply, tells a more complicated story than most people realize
It also boosts Type III collagen, which provides flexibility and supports blood vessels and organs
Some patients eventually stop taking GLP-1s, either voluntarily or due to access barriers
Most PlexusDx patients report reduced hunger within days and measurable weight loss (12 pounds per week) beginning in weeks 24 of consistent semaglutide injection use
It is also not recommended for use in people with type-1 diabetes or a history of pancreatitis, and those already on other blood sugar lowering medications should avoid using semaglutide